Eyeworld

JUL 2021

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1381991

Contents of this Issue

Navigation

Page 73 of 146

JULY 2021 | WHITE PAPER | 71 Sponsored by Regener-Eyes ® was immediately removed due to the pa- tient's significant pain. T.R. was taking pre- servative-free tears q 2 hours while awake OU and bland ointment OU at night. On presentation, her best corrected acuities were 20/30 OD and 20/40 OS. A slit lamp exam revealed a 3 X 5 mm epithelial defect in the mid-peripheral cornea OS, in the su- pertemporal quadrant at 2 o'clock. Regener-Eyes ® Professional Strength QID OU was begun; preservative-free tears q 2 hours while awake OU and bland oint- ment QHS OU were continued. On T.R.'s next visit 1 week later, the epithelial defect was healed for the first time in 4 months. The current regimen was continued. Meibomian gland dysfunction (MGD)/meibomian gland regeneration (MGR) Meibomian gland dropout and altered meibum secretion were usually seen in the patients suf- fering from DED. 19–20 Both congenital and ac- quired meibomian gland dysfunction (MGD) results in increased tear film osmolarity and leads to the development of evaporative DED. 19–20 We recently demonstrated the ben- eficial effects of Regener-Eyes ® in the treat- ment of MGD-related DED. 13 In one case report, Regener-Eyes ® promoted regeneration of in- jured meibomian glands and efficiently attenuat- ed DED-related symptoms in a patient suffering from MGD. 13 Before the topical application of Regener-Eyes ® , the meibomian ducts of this MGD patient were dilated, exhibiting enlargement and now been on Regener-Eyes ® Professional Strength for 4 months and is symptom-free. Case #2, S.P. A 46-year-old male with Sjögren's syndrome presented with extreme pain in both eyes and blurred vision. He was taking cyclo- sporine emulsion BID OU, preservative-free tears q 1 hour while awake OU, serum tears q 2 hours while awake, bland nighttime ointments OU, and omega-3 nutritional sup- plements, with minimal relief. S.P.'s best corrected visual acuity was 20/100 OD and 20/70 OS. His most re- markable findings on slit lamp exam were 4+ corneal filaments OD, 2+–4+ OS, and a markedly decreased tear meniscus OU. His tear osmolarity readings were 391 mOsm/L OD and 359 OS. Regener-Eyes ® Professional Strength QID OU was added to the above regimen, with the exception of serum tears, which he was advised to discontinue. S.P. returned after 1 month with a best corrected visual acuity of 20/50 OD and 20/40 OS, with 2+ filaments OD and 1+–2+ OS. His pain is much improved. He is continuing his cur- rent regimen and will return in 2 months. Case #3, T.R. A 64-year-old female with a long histo- ry of Sjögren's syndrome presented with a non-healing epithelial defect OS. She had been given a course of valacyclovir 1 gram PO TID X 10 days, as well as Zirgan gel (ganciclovir, Bausch + Lomb) 5 X a day OS for 10 days, with no improvement. An amniotic membrane had been inserted but continued on page 72

Articles in this issue

Archives of this issue

view archives of Eyeworld - JUL 2021